featured
ACC.15: Alirocumab Reduces LDL Levels in the ODESSEY Trial
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine